Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... twice daily from a Diskus™ inhaler for a 4-week ...

The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired ... twice daily treatment of asthma in patients age four and ...

Seretide (salmeterol xinafoate/fluticasone propionate) – sold as Advair in ... the burden of asthma on the NHS. However, Seretide is available both as a pMDI and in the Diskus dry powder inhaler ...

Dec. 25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...